Toward the Broad Adoption of 3D Tumor Models in the Cancer Drug Pipeline

ACS Biomaterials Science and Engineering

Volumn 1, Issue 10, 2015, Pages 877-894

  Cox, Megan C ^a   Reese, Laura M ^a   Bickford, Lissett R ^a   Verbridge, Scott S ^a  

^a VIRGINIA POLYTECHNIC INSTITUTE AND STATE UNIVERSITY   (United States)

Author keywords

cancer; drug testing; heterogeneous models; tumor microenvironment

Indexed keywords

ANTINEOPLASTIC AGENT; BIOMATERIAL; CYTARABINE; DOXORUBICIN; MAGNETIC NANOPARTICLE; NANOCARRIER; PACLITAXEL; SONOLISIB; TRASTUZUMAB; WORTMANNIN;

ANTINEOPLASTIC ACTIVITY; CANCER CELL LINE; CANCER CHEMOTHERAPY; CANCER RESISTANCE; CELL CULTURE; CELL INTERACTION; DRUG DELIVERY SYSTEM; DRUG DESIGN; DRUG EFFICACY; DRUG INDUSTRY; DRUG SAFETY; DRUG SCREENING; EXTRACELLULAR MATRIX; GLIOBLASTOMA; HUMAN; HYDROGEL; IN VITRO STUDY; MICROFLUIDICS; NEOPLASM; NONHUMAN; PATENT; PERSONALIZED MEDICINE; PHARMACOKINETIC PARAMETERS; PREDICTIVE VALUE; PRIORITY JOURNAL; REVIEW; TUMOR MICROENVIRONMENT; TUMOR MODEL; TUMOR SPHEROID; VASCULAR TUMOR;

EID: 84991521860     PISSN: None     EISSN: 23739878     Source Type: Journal    
DOI: 10.1021/acsbiomaterials.5b00172     Document Type: Review

References (160)

1. Håkanson, M.; Cukierman, E.; Charnley, M. Miniaturized pre-clinical cancer models as research and diagnostic tools Adv. Drug Delivery Rev. 2014, 69, 52-66 10.1016/j.addr.2013.11.010
2. Chabner, B. A.; Roberts, T. G. Chemotherapy and the war on cancer Nat. Rev. Cancer 2005, 5 (1) 65-72 10.1038/nrc1529
3. DiMasi, J. A.; Hansen, R. W.; Grabowski, H. G. The price of innovation: new estimates of drug development costs J. Health Econ 2003, 22 (2) 151-85 10.1016/S0167-6296(02)00126-1
4. Gevaert, M. Engineering 3D Tissue Systems to Better Mimic Human Biology. Natl. Acad. Eng. 2012, 42 (4).
5. Sutherland, R. M.; McCredie, J. A.; Inch, W. R. Growth of multicell spheroids in tissue culture as a model of nodular carcinomas J. Natl. Cancer Inst. 1971, 46 (1) 113-120
6. Theodorescu, D.; Sheehan, C.; Kerbel, R. TGF-β gene expression depends on tissue architecture In Vitro Cell. Dev. Biol. 1993, 29 (2) 105-108 10.1007/BF02630937
7. Croix, B. S.; Flørenes, V. A.; Rak, J. W.; Flanagan, M.; Bhattacharya, N.; Slingerland, J. M.; Kerbel, R. S. Impact of the cyclin-dependent kinase inhibitor p27Kip1 on resistance of tumor cells to anticancer agents Nat. Med. 1996, 2 (11) 1204-1210 10.1038/nm1196-1204
8. Weaver, V. M.; Lelièvre, S.; Lakins, J. N.; Chrenek, M. A.; Jones, J. C.; Giancotti, F.; Werb, Z.; Bissell, M. J. β4 integrin-dependent formation of polarized three-dimensional architecture confers resistance to apoptosis in normal and malignant mammary epithelium Cancer Cell 2002, 2 (3) 205-216 10.1016/S1535-6108(02)00125-3
9. Schmeichel, K. L.; Bissell, M. J. Modeling tissue-specific signaling and organ function in three dimensions J. Cell Sci. 2003, 116 (12) 2377-2388 10.1242/jcs.00503
10. Radisky, D.; Muschler, J.; Bissell, M. J. Order and disorder: the role of extracellular matrix in epithelial cancer Cancer Invest. 2002, 20 (1) 139-153 10.1081/CNV-120000374
11. Aljitawi, O. S.; Li, D.; Xiao, Y.; Zhang, D.; Ramachandran, K.; Stehno-Bittel, L.; Van Veldhuizen, P.; Lin, T. L.; Kambhampati, S.; Garimella, R. A novel three-dimensional stromal-based model for in vitro chemotherapy sensitivity testing of leukemia cells Leuk. Lymphoma 2014, 55 (2) 378-391 10.3109/10428194.2013.793323
12. Biggs, T.; Foreman, J.; Sundstrom, L.; Regenass, U.; Lehembre, F. Antitumor compound testing in glioblastoma organotypic brain cultures J. Biomol. Screening 2011, 16 (8) 805-817 10.1177/1087057111414895
13. Stewart, D. J.; Richard, M. T.; Benoit, B.; Hugenholtz, H.; Russell, N.; Dennery, J.; Peterson, E.; Grahovac, Z.; Belanger, G.; Aitkens, S. Cisplatin plus cytosine arabinoside in adults with malignant gliomas J. Neuro-Oncol. 1984, 2 (1) 29-34 10.1007/BF00165155
14. Swinnen, L. J.; Rankin, C.; Carraway, H.; Albain, K. S.; Townsend, J. J.; Budd, G. T.; Kish, J. A.; Rivkin, S. E.; Blumenthal, D. T. A phase II study of cisplatin preceded by a 12-h continuous infusion of concurrent hydroxyurea and cytosine arabinoside (Ara-C) for adult patients with malignant gliomas (Southwest Oncology Group S9149) J. Neuro-Oncol. 2008, 86 (3) 353-358 10.1007/s11060-007-9483-3
15. Smith, S. J.; Wilson, M.; Ward, J. H.; Rahman, C. V.; Peet, A. C.; Macarthur, D. C.; Rose, F. R.; Grundy, R. G.; Rahman, R. Recapitulation of tumor heterogeneity and molecular signatures in a 3D brain cancer model with decreased sensitivity to histone deacetylase inhibition PLoS One 2012, 7 (12) e52335 10.1371/journal.pone.0052335
16. Hongisto, V.; Jernström, S.; Fey, V.; Mpindi, J.-P.; Sahlberg, K. K.; Kallioniemi, O.; Perälä, M. High-throughput 3D screening reveals differences in drug sensitivities between culture models of JIMT1 breast cancer cells PLoS One 2013, 8 (10) e77232 10.1371/journal.pone.0077232
17. Pickl, M.; Ries, C. Comparison of 3D and 2D tumor models reveals enhanced HER2 activation in 3D associated with an increased response to trastuzumab Oncogene 2009, 28 (3) 461-468 10.1038/onc.2008.394
18. Howes, A. L.; Chiang, G. G.; Lang, E. S.; Ho, C. B.; Powis, G.; Vuori, K.; Abraham, R. T. The phosphatidylinositol 3-kinase inhibitor, PX-866, is a potent inhibitor of cancer cell motility and growth in three-dimensional cultures Mol. Cancer Ther. 2007, 6 (9) 2505-2514 10.1158/1535-7163.MCT-06-0698
19. Weinstein, J. N. Omic'and hypothesis-driven research in the molecular pharmacology of cancer Curr. Opin. Pharmacol. 2002, 2 (4) 361-365 10.1016/S1471-4892(02)00185-6
20. Sos, M. L.; Michel, K.; Zander, T.; Weiss, J.; Frommolt, P.; Peifer, M.; Li, D.; Ullrich, R.; Koker, M.; Fischer, F. Predicting drug susceptibility of non-small cell lung cancers based on genetic lesions J. Clin. Invest. 2009, 119 (6) 1727-1740 10.1172/JCI37127
21. Mehta, G.; Hsiao, A. Y.; Ingram, M.; Luker, G. D.; Takayama, S. Opportunities and challenges for use of tumor spheroids as models to test drug delivery and efficacy J. Controlled Release 2012, 164 (2) 192-204 10.1016/j.jconrel.2012.04.045
22. Gieni, R. S.; Hendzel, M. J. Mechanotransduction from the ECM to the genome: are the pieces now in place? J. Cell. Biochem. 2008, 104 (6) 1964-1987 10.1002/jcb.21364
23. Zohrabian, V. M.; Forzani, B.; Chau, Z.; Murali, R.; Jhanwar-Uniyal, M. Rho/ROCK and MAPK signaling pathways are involved in glioblastoma cell migration and proliferation Anticancer Res. 2009, 29 (1) 119-123
24. Rathinam, R.; Berrier, A.; Alahari, S. K. Role of Rho GTPases and their regulators in cancer progression Front. Biosci., Landmark Ed. 2011, 16 (1) 2561-2571 10.2741/3872
25. Bremnes, R. M.; Dønnem, T.; Al-Saad, S.; Al-Shibli, K.; Andersen, S.; Sirera, R.; Camps, C.; Marinez, I.; Busund, L.-T. The role of tumor stroma in cancer progression and prognosis: emphasis on carcinoma-associated fibroblasts and non-small cell lung cancer J. Thorac. Oncol. 2011, 6 (1) 209-217 10.1097/JTO.0b013e3181f8a1bd
26. Thoma, C. R.; Zimmermann, M.; Agarkova, I.; Kelm, J. M.; Krek, W. 3D cell culture systems modeling tumor growth determinants in cancer target discovery Adv. Drug Delivery Rev. 2014, 69, 29-41 10.1016/j.addr.2014.03.001
27. Griguer, C. E.; Oliva, C. R.; Gillespie, G. Y. Glucose metabolism heterogeneity in human and mouse malignant glioma cell lines J. Neuro-Oncol. 2005, 74 (2) 123-133 10.1007/s11060-004-6404-6
28. Semenza, G. L. Hypoxia-inducible factors: mediators of cancer progression and targets for cancer therapy Trends Pharmacol. Sci. 2012, 33 (4) 207-214 10.1016/j.tips.2012.01.005
29. Guzy, R. D.; Hoyos, B.; Robin, E.; Chen, H.; Liu, L.; Mansfield, K. D.; Simon, M. C.; Hammerling, U.; Schumacker, P. T. Mitochondrial complex III is required for hypoxia-induced ROS production and cellular oxygen sensing Cell Metab. 2005, 1 (6) 401-408 10.1016/j.cmet.2005.05.001
30. Turner, N. C.; Reis-Filho, J. S. Genetic heterogeneity and cancer drug resistance Lancet Oncol. 2012, 13 (4) e178-e185 10.1016/S1470-2045(11)70335-7
31. Pampaloni, F.; Reynaud, E. G.; Stelzer, E. H. The third dimension bridges the gap between cell culture and live tissue Nat. Rev. Mol. Cell Biol. 2007, 8 (10) 839-845 10.1038/nrm2236
32. Lutolf, M.; Hubbell, J. Synthetic biomaterials as instructive extracellular microenvironments for morphogenesis in tissue engineering Nat. Biotechnol. 2005, 23 (1) 47-55 10.1038/nbt1055
33. Cushing, M. C.; Anseth, K. S. Hydrogel cell cultures Science 2007, 316 (5828) 1133-1134 10.1126/science.1140171
34. Song, H.-H. G.; Park, K. M.; Gerecht, S. Hydrogels to model 3D in vitro microenvironment of tumor vascularization Adv. Drug Delivery Rev. 2014, 79, 19-29 10.1016/j.addr.2014.06.002
35. Benton, G.; Kleinman, H. K.; George, J.; Arnaoutova, I. Multiple uses of basement membrane-like matrix (BME/Matrigel) in vitro and in vivo with cancer cells Int. J. Cancer 2011, 128 (8) 1751-1757 10.1002/ijc.25781
36. Shoulders, M. D.; Raines, R. T. Collagen structure and stability Annu. Rev. Biochem. 2009, 78, 929 10.1146/annurev.biochem.77.032207.120833
37. Infanger, D. W.; Lynch, M. E.; Fischbach, C. Engineered culture models for studies of tumor-microenvironment interactions Annu. Rev. Biomed. Eng. 2013, 15, 29-53 10.1146/annurev-bioeng-071811-150028
38. Kosaki, R.; Watanabe, K.; Yamaguchi, Y. Overproduction of hyaluronan by expression of the hyaluronan synthase Has2 enhances anchorage-independent growth and tumorigenicity Cancer Res. 1999, 59 (5) 1141-1145
39. Bharadwaj, A. G.; Kovar, J. L.; Loughman, E.; Elowsky, C.; Oakley, G. G.; Simpson, M. A. Spontaneous metastasis of prostate cancer is promoted by excess hyaluronan synthesis and processing Am. J. Pathol. 2009, 174 (3) 1027-1036 10.2353/ajpath.2009.080501
40. Hanjaya-Putra, D.; Bose, V.; Shen, Y.-I.; Yee, J.; Khetan, S.; Fox-Talbot, K.; Steenbergen, C.; Burdick, J. A.; Gerecht, S. Controlled activation of morphogenesis to generate a functional human microvasculature in a synthetic matrix Blood 2011, 118 (3) 804-815 10.1182/blood-2010-12-327338
41. Mata, E.; Igartua, M.; Patarroyo, M. E.; Pedraz, J. L.; Hernández, R. M. Enhancing immunogenicity to PLGA microparticulate systems by incorporation of alginate and RGD-modified alginate Eur. J. Pharm. Sci. 2011, 44 (1) 32-40 10.1016/j.ejps.2011.05.015
42. Fischbach, C.; Kong, H. J.; Hsiong, S. X.; Evangelista, M. B.; Yuen, W.; Mooney, D. J. Cancer cell angiogenic capability is regulated by 3D culture and integrin engagement Proc. Natl. Acad. Sci. U. S. A. 2009, 106 (2) 399-404 10.1073/pnas.0808932106
43. Tibbitt, M. W.; Anseth, K. S. Hydrogels as extracellular matrix mimics for 3D cell culture Biotechnol. Bioeng. 2009, 103 (4) 655-663 10.1002/bit.22361
44. Tung, Y.-C.; Hsiao, A. Y.; Allen, S. G.; Torisawa, Y.-s.; Ho, M.; Takayama, S. High-throughput 3D spheroid culture and drug testing using a 384 hanging drop array Analyst 2011, 136 (3) 473-478 10.1039/C0AN00609B
45. Birgersdotter, A.; Sandberg, R.; Ernberg, I. Gene expression perturbation in vitro-a growing case for three-dimensional (3D) culture systems Sem. Cancer Biol. 2005, 5, 405-412 10.1016/j.semcancer.2005.06.009
46. Bates, R. C.; Edwards, N. S.; Yates, J. D. Spheroids and cell survival Crit. Rev. Oncol./Hematol. 2000, 36 (2) 61-74 10.1016/S1040-8428(00)00077-9
47. Buffa, F. M.; West, C.; Byrne, K.; Moore, J. V.; Nahum, A. E. Radiation response and cure rate of human colon adenocarcinoma spheroids of different size: the significance of hypoxia on tumor control modelling Int. J. Radiat. Oncol., Biol., Phys. 2001, 49 (4) 1109-1118 10.1016/S0360-3016(00)01533-9
48. Frankel, A.; Buckman, R.; Kerbel, R. S. Abrogation of taxol-induced G2-M arrest and apoptosis in human ovarian cancer cells grown as multicellular tumor spheroids Cancer Res. 1997, 57 (12) 2388-2393
49. Nicholson, K.; Bibby, M.; Phillips, R. Influence of drug exposure parameters on the activity of paclitaxel in multicellular spheroids Eur. J. Cancer 1997, 33 (8) 1291-1298 10.1016/S0959-8049(97)00114-7
50. Fennema, E.; Rivron, N.; Rouwkema, J.; van Blitterswijk, C.; de Boer, J. Spheroid culture as a tool for creating 3D complex tissues Trends Biotechnol. 2013, 31 (2) 108-115 10.1016/j.tibtech.2012.12.003
51. Khanna, S.; Bhatt, A. N.; Dwarakanath, B. S. Multicellular Spheroid: 3-D Tissue Culture Model for Cancer Research. In Animal Biotechnology; Verma, A. S.; Singh, A., Eds.; Academic Press: San Diego, 2014; Chapter 11, pp 195-210.
52. Johnson, E.; Theisen, C. S.; Johnson, K. R.; Wheelock, M. J. R-cadherin influences cell motility via Rho family GTPases J. Biol. Chem. 2004, 279 (30) 31041-31049 10.1074/jbc.M400024200
53. Lovitt, C. J.; Shelper, T. B.; Avery, V. M. Advanced cell culture techniques for cancer drug discovery Biology 2014, 3 (2) 345-367 10.3390/biology3020345
54. Kelm, J. M.; Timmins, N. E.; Brown, C. J.; Fussenegger, M.; Nielsen, L. K. Method for generation of homogeneous multicellular tumor spheroids applicable to a wide variety of cell types Biotechnol. Bioeng. 2003, 83 (2) 173-180 10.1002/bit.10655
55. Lin, R. Z.; Chang, H. Y. Recent advances in three-dimensional multicellular spheroid culture for biomedical research Biotechnol. J. 2008, 3 (9-10) 1172-1184 10.1002/biot.200700228
56. Valcárcel, M.; Arteta, B.; Jaureguibeitia, A.; Lopategi, A.; Martínez, I.; Mendoza, L.; Muruzabal, F. J.; Salado, C.; Vidal-Vanaclocha, F. Three-dimensional growth as multicellular spheroid activates the proangiogenic phenotype of colorectal carcinoma cells via LFA-1-dependent VEGF: implications on hepatic micrometastasis J. Transl. Med. 2008, 6 (9) 57 10.1186/1479-5876-6-57
57. Krueger, S.; Kalinski, T.; Wolf, H.; Kellner, U.; Roessner, A. Interactions between human colon carcinoma cells, fibroblasts and monocytic cells in coculture-regulation of cathepsin B expression and invasiveness Cancer Lett. 2005, 223 (2) 313-322 10.1016/j.canlet.2004.09.050
58. Hsiao, A. Y.; Tung, Y. C.; Qu, X.; Patel, L. R.; Pienta, K. J.; Takayama, S. 384 hanging drop arrays give excellent Z-factors and allow versatile formation of co-culture spheroids Biotechnol. Bioeng. 2012, 109 (5) 1293-1304 10.1002/bit.24399
59. Sadanandam, A.; Varney, M. L.; Singh, S.; Ashour, A. E.; Moniaux, N.; Deb, S.; Lele, S. M.; Batra, S. K.; Singh, R. K. High gene expression of semaphorin 5A in pancreatic cancer is associated with tumor growth, invasion and metastasis Int. J. Cancer 2010, 127 (6) 1373-1383 10.1002/ijc.25166
60. Pinke, D. E.; Kalloger, S. E.; Francetic, T.; Huntsman, D. G.; Lee, J. M. The prognostic significance of elongation factor eEF1A2 in ovarian cancer Gynecol. Oncol. 2008, 108 (3) 561-568 10.1016/j.ygyno.2007.11.019
61. Timmins, N. E.; Nielsen, L. K., Generation of multicellular tumor spheroids by the hanging-drop method. In Tissue Engineering; Springer: New York, 2007; pp 141-151.
62. DANEN, E. H. J.; De, S. J.; TRUONG, H. H. Method for obtaining a multicellular spheroid. Patent US 20140221225 A1.
63. Fischbach, C. Pathologically relevant tumor microenvironments for high-throughput drug screening. Patent US 20100056390 A1.
64. Morgan, J. R.; Achilli, T. M.; Tripathi, A.; McCalla, S., Differential effects of drugs on transport in a multi-layer 3d spheroid model. Patent US 20130079288 A1.
65. Khandare, J. J.; Jalota-Badhwar, A., Hollow polymer microspheres as three-dimensional cell culture matrix. Patent WO 2013050921 A1.
66. Koutsiaris, A. G.; Tachmitzi, S. V.; Batis, N.; Kotoula, M. G.; Karabatsas, C. H.; Tsironi, E.; Chatzoulis, D. Z. Volume flow and wall shear stress quantification in the human conjunctival capillaries and post-capillary venules in vivo Biorheology 2006, 44 (5-6) 375-386
67. Resnick, N.; Yahav, H.; Shay-Salit, A.; Shushy, M.; Schubert, S.; Zilberman, L. C. M.; Wofovitz, E. Fluid shear stress and the vascular endothelium: for better and for worse Prog. Biophys. Mol. Biol. 2003, 81 (3) 177-199 10.1016/S0079-6107(02)00052-4
68. Buchanan, C. F.; Verbridge, S. S.; Vlachos, P. P.; Rylander, M. N. Flow Shear Stress Regulates Endothelial Barrier Function and Expression of Angiogenic Factors in a 3D Microfluidic Tumor Vascular Model Cell Adhes. Migr. 2014, 8, 517-524 10.4161/19336918.2014.970001
69. Wirtz, D.; Konstantopoulos, K.; Searson, P. C. The physics of cancer: the role of physical interactions and mechanical forces in metastasis Nat. Rev. Cancer 2011, 11 (7) 512-522 10.1038/nrc3080
70. Lovett, M.; Lee, K.; Edwards, A.; Kaplan, D. L. Vascularization strategies for tissue engineering Tissue Eng., Part B 2009, 15 (3) 353-370 10.1089/ten.teb.2009.0085
71. Kamm, R. D.; Asada, H. H.; Farahat, W. A.; Zervantonakis, I. K.; Wood, L. B.; Kothapalli, C.; Chung, S.; Macklis, J. D.; Tharin, S.; Varner, J., Device For High Throughput Investigations Of Multi-Cellular Interactions. Patent US 20140057311 A1.
72. Zaman, M. H.; Trapani, L. M.; Sieminski, A. L.; MacKellar, D.; Gong, H.; Kamm, R. D.; Wells, A.; Lauffenburger, D. A.; Matsudaira, P. Migration of tumor cells in 3D matrices is governed by matrix stiffness along with cell-matrix adhesion and proteolysis Proc. Natl. Acad. Sci. U. S. A. 2006, 103 (29) 10889-10894 10.1073/pnas.0604460103
73. Park, Y. K.; Tu, T.-Y.; Lim, S. H.; Clement, I. J.; Yang, S. Y.; Kamm, R. D. In Vitro Microvessel Growth and Remodeling within a Three-Dimensional Microfluidic Environment Cell. Mol. Bioeng. 2014, 7 (1) 15-25 10.1007/s12195-013-0315-6
74. Niu, Y.; Bai, J.; Kamm, R. D.; Wang, Y.; Wang, C. Validating Antimetastatic Effects of Natural Products in an Engineered Microfluidic Platform Mimicking Tumor Microenvironment Mol. Pharmaceutics 2014, 11, 2022 10.1021/mp500054h
75. Pesen, O. D., Three dimensional microfluidic device that determines metastatic capacity and homing choices. Patent EP 2741083 B1.
76. George, S. C.; Hughes, C. C. W.; Lee, A. P.; Moya, M.; Hsu, Y. H., High-Throughput Platform Comprising Microtissues Perfused With Living Microvessels. Patent US 20120083425 A1.
77. Weigelt, B.; Peterse, J. L.; Van't Veer, L. J. Breast cancer metastasis: markers and models Nat. Rev. Cancer 2005, 5 (8) 591-602 10.1038/nrc1670
78. Mattix, B.; Olsen, T. R.; Gu, Y.; Casco, M.; Herbst, A.; Simionescu, D. T.; Visconti, R. P.; Kornev, K. G.; Alexis, F. Biological magnetic cellular spheroids as building blocks for tissue engineering Acta Biomater. 2014, 10 (2) 623-9 10.1016/j.actbio.2013.10.021
79. Mattix, B. M.; Olsen, T. R.; Casco, M.; Reese, L.; Poole, J. T.; Zhang, J.; Visconti, R. P.; Simionescu, A.; Simionescu, D. T.; Alexis, F. Janus magnetic cellular spheroids for vascular tissue engineering Biomaterials 2014, 35 (3) 949-60 10.1016/j.biomaterials.2013.10.036
80. Takayama, S.; Tung, Y.-C.; Hsiao, A. Y.-C.; Jan, E. Hanging drop devices, systems and/or methods. Patent US 8906685 B2.
81. Lichtenberg, J.; Moritz, W.; Kelm, J. Compliant multi-well plate. Patent WO 2012014047 A1.
82. Amann, A.; Zwierzina, M.; Gamerith, G.; Bitsche, M.; Huber, J. M.; Vogel, G. F.; Blumer, M.; Koeck, S.; Pechriggl, E. J.; Kelm, J. M. Development of an Innovative 3D Cell Culture System to Study Tumour-Stroma Interactions in Non-Small Cell Lung Cancer Cells PLoS One 2014, 9 (3) e92511 10.1371/journal.pone.0092511
83. Mirmalek-Sani, S.-H.; Orlando, G.; McQuilling, J. P.; Pareta, R.; Mack, D. L.; Salvatori, M.; Farney, A. C.; Stratta, R. J.; Atala, A.; Opara, E. C. Porcine pancreas extracellular matrix as a platform for endocrine pancreas bioengineering Biomaterials 2013, 34 (22) 5488-5495 10.1016/j.biomaterials.2013.03.054
84. InSphero InSphero Profile. http://www.insphero.com/company (accessed March 15, 2015).
85. Tseng, H.; Gage, J. A.; Raphael, R. M.; Moore, R. H.; Killian, T. C.; Grande-Allen, K. J.; Souza, G. R. Assembly of a three-dimensional multitype bronchiole coculture model using magnetic levitation Tissue Eng., Part C 2013, 19 (9) 665-675 10.1089/ten.tec.2012.0157
86. Gevaert, M. R.; Orr, D. E.; Widener, M. R., Bioreactor system. Patent US 20130309771 A1.
87. Gevaert, M. R.; Orr, D. E., Co-culture bioreactor system. Patent US 8865460 B2.
88. Orr, D. E.; Burg, K. J. Design of a modular bioreactor to incorporate both perfusion flow and hydrostatic compression for tissue engineering applications Ann. Biomed. Eng. 2008, 36 (7) 1228-1241 10.1007/s10439-008-9505-0
89. Hal, C. The 3DKUBE segregated co-culture system: optimal tumor-stromal interactions for modeling the tumor microenvironment in anticancer therapeutic development. In 104th Annual Meeting of the American Association for Cancer Research; American Association for Cancer Research: Washington, D.C., 2013; p 1102.
90. Prabhakarpandian, B.; Pant, K.; Sundaram, S. Microfluidic assay for selection and optimization of drug delivery vehicles to tumors. Patent US 20130101991 A1.
91. Rosano, J. M.; Tousi, N.; Scott, R. C.; Krynska, B.; Rizzo, V.; Prabhakarpandian, B.; Pant, K.; Sundaram, S.; Kiani, M. F. A physiologically realistic in vitro model of microvascular networks Biomed. Microdevices 2009, 11 (5) 1051-1057 10.1007/s10544-009-9322-8
92. Li, A. P.; Bode, C.; Sakai, Y. A novel in vitro system, the integrated discrete multiple organ cell culture (IdMOC) system, for the evaluation of human drug toxicity: comparative cytotoxicity of tamoxifen towards normal human cells from five major organs and MCF-7 adenocarcinoma breast cancer cells Chem.-Biol. Interact. 2004, 150 (1) 129-136 10.1016/j.cbi.2004.09.010
93. Vulto, P.; Urban, G.; Podszun, S. Phaseguide patterns for liquid manipulation. Patent US 20120097272 A1.
94. Drifka, C. R.; Eliceiri, K. W.; Weber, S. M.; Kao, W. J. A bioengineered heterotypic stroma-cancer microenvironment model to study pancreatic ductal adenocarcinoma Lab Chip 2013, 13 (19) 3965-3975 10.1039/c3lc50487e
95. Dufau, I.; Frongia, C.; Sicard, F.; Dedieu, L.; Cordelier, P.; Ausseil, F.; Ducommun, B.; Valette, A. Multicellular tumor spheroid model to evaluate spatio-temporal dynamics effect of chemotherapeutics: application to the gemcitabine/CHK1 inhibitor combination in pancreatic cancer BMC Cancer 2012, 12 (1) 15 10.1186/1471-2407-12-15
96. Loessner, D.; Stok, K. S.; Lutolf, M. P.; Hutmacher, D. W.; Clements, J. A.; Rizzi, S. C. Bioengineered 3D platform to explore cell-ECM interactions and drug resistance of epithelial ovarian cancer cells Biomaterials 2010, 31 (32) 8494-8506 10.1016/j.biomaterials.2010.07.064
97. Ohmori, T.; Yang, J.-L.; Price, J. O.; Arteaga, C. L. Blockade of tumor cell transforming growth factor-βs enhances cell cycle progression and sensitizes human breast carcinoma cells to cytotoxic chemotherapy Exp. Cell Res. 1998, 245 (2) 350-359 10.1006/excr.1998.4261
98. Takagi, A.; Watanabe, M.; Ishii, Y.; Morita, J.; Hirokawa, Y.; Matsuzaki, T.; Shiraishi, T. Three-dimensional cellular spheroid formation provides human prostate tumor cells with tissue-like features Anticancer Res. 2007, 27 (1A) 45-53
99. Beebe, D. J.; Mensing, G. A.; Walker, G. M. Physics and applications of microfluidics in biology Annu. Rev. Biomed. Eng. 2002, 4 (1) 261-286 10.1146/annurev.bioeng.4.112601.125916
100. Young, E. W.; Beebe, D. J. Fundamentals of microfluidic cell culture in controlled microenvironments Chem. Soc. Rev. 2010, 39 (3) 1036-1048 10.1039/b909900j
101. Choi, N. W.; Verbridge, S. S.; Williams, R. M.; Park, K.-Y.; Zipfel, W. R.; Fischbach, C.; Stroock, A. D. Oxygen-Sensing Microfluidic Scaffolds. In ASME 2009 7th International Conference on Nanochannels, Microchannels, and Minichannels; American Society of Mechanical Engineers: New York, 2009; pp 1185-1189.
102. Kwon, Y.; Smith, B.; Zhou, Y.; Kaufman, M.; Godwin, A. Effective inhibition of c-MET-mediated signaling, growth and migration of ovarian cancer cells is influenced by the ovarian tissue microenvironment Oncogene 2015, 34, 144 10.1038/onc.2013.539
103. Sung, K. E.; Su, X.; Berthier, E.; Pehlke, C.; Friedl, A.; Beebe, D. J. Understanding the impact of 2D and 3D fibroblast cultures on in vitro breast cancer models PLoS One 2013, 8 (10) e76373 10.1371/journal.pone.0076373
104. Müerköster, S.; Wegehenkel, K.; Arlt, A.; Witt, M.; Sipos, B.; Kruse, M.-L.; Sebens, T.; Klöppel, G.; Kalthoff, H.; Fölsch, U. R.; Schäfer, H. Tumor Stroma Interactions Induce Chemoresistance in Pancreatic Ductal Carcinoma Cells Involving Increased Secretion and Paracrine Effects of Nitric Oxide and Interleukin-1β Cancer Res. 2004, 64 (4) 1331-1337
105. Chandler, E. M.; Seo, B. R.; Califano, J. P.; Eguiluz, R. C. A.; Lee, J. S.; Yoon, C. J.; Tims, D. T.; Wang, J. X.; Cheng, L.; Mohanan, S. et al. Implanted adipose progenitor cells as physicochemical regulators of breast cancer Proc. Natl. Acad. Sci. U. S. A. 2012, 109 (25) 9786-9791 10.1073/pnas.1121160109
106. Ricci-Vitiani, L.; Pallini, R.; Biffoni, M.; Todaro, M.; Invernici, G.; Cenci, T.; Maira, G.; Parati, E. A.; Stassi, G.; Larocca, L. M. Tumour vascularization via endothelial differentiation of glioblastoma stem-like cells Nature 2010, 468 (7325) 824-828 10.1038/nature09557
107. Duyverman, A. M.; Steller, E. J.; Fukumura, D.; Jain, R. K.; Duda, D. G. Studying primary tumor-associated fibroblast involvement in cancer metastasis in mice Nat. Protoc. 2012, 7 (4) 756-762 10.1038/nprot.2012.031
108. Khamis, Z. I.; Sahab, Z. J.; Sang, Q.-X. A. Active roles of tumor stroma in breast cancer metastasis Int. J. Breast Cancer 2012, 2012, 1 10.1155/2012/574025
109. Stylianopoulos, T.; Martin, J. D.; Chauhan, V. P.; Jain, S. R.; Diop-Frimpong, B.; Bardeesy, N.; Smith, B. L.; Ferrone, C. R.; Hornicek, F. J.; Boucher, Y. et al. Causes, consequences, and remedies for growth-induced solid stress in murine and human tumors Proc. Natl. Acad. Sci. U. S. A. 2012, 109 (38) 15101-15108 10.1073/pnas.1213353109
110. Provenzano, P. P.; Cuevas, C.; Chang, A. E.; Goel, V. K.; Von Hoff, D. D.; Hingorani, S. R. Enzymatic targeting of the stroma ablates physical barriers to treatment of pancreatic ductal adenocarcinoma Cancer Cell 2012, 21 (3) 418-429 10.1016/j.ccr.2012.01.007
111. Neesse, A.; Michl, P.; Frese, K. K.; Feig, C.; Cook, N.; Jacobetz, M. A.; Lolkema, M. P.; Buchholz, M.; Olive, K. P.; Gress, T. M. Stromal biology and therapy in pancreatic cancer Gut 2011, 60, 861 10.1136/gut.2010.226092
112. Pérez-Mancera, P. A.; Guerra, C.; Barbacid, M.; Tuveson, D. A. What we have learned about pancreatic cancer from mouse models Gastroenterology 2012, 142 (5) 1079-1092 10.1053/j.gastro.2012.03.002
113. Shanks, N.; Greek, R.; Greek, J. Are animal models predictive for humans? Philos. Ethics Humanit Med. 2009, 4, 2 10.1186/1747-5341-4-2
114. Morgan, J. P.; Delnero, P. F.; Zheng, Y.; Verbridge, S. S.; Chen, J.; Craven, M.; Choi, N. W.; Diaz-Santana, A.; Kermani, P.; Hempstead, B. et al. Formation of microvascular networks in vitro Nat. Protoc. 2013, 8 (9) 1820-1836 10.1038/nprot.2013.110
115. Hribar, K. C.; Choi, Y. S.; Ondeck, M.; Engler, A. J.; Chen, S. Digital Plasmonic Patterning for Localized Tuning of Hydrogel Stiffness Adv. Funct. Mater. 2014, 24, 4922 10.1002/adfm.201400274
116. Verbridge, S. S.; Chakrabarti, A.; DelNero, P.; Kwee, B.; Varner, J. D.; Stroock, A. D.; Fischbach, C. Physicochemical regulation of endothelial sprouting in a 3D microfluidic angiogenesis model J. Biomed. Mater. Res., Part A 2013, 101 (10) 2948-2956 10.1002/jbm.a.34587
117. Walsh, C. L.; Babin, B. M.; Kasinskas, R. W.; Foster, J. A.; McGarry, M. J.; Forbes, N. S. A multipurpose microfluidic device designed to mimic microenvironment gradients and develop targeted cancer therapeutics Lab Chip 2009, 9 (4) 545-554 10.1039/B810571E
118. Mahadik, B. P.; Wheeler, T. D.; Skertich, L. J.; Kenis, P. J.; Harley, B. A. Microfluidic generation of gradient hydrogels to modulate hematopoietic stem cell culture environment Adv. Healthcare Mater. 2014, 3 (3) 449-458 10.1002/adhm.201300263
119. Orsi, G.; Fagnano, M.; De Maria, C.; Montemurro, F.; Vozzi, G., A new 3D concentration gradient maker and its application in building hydrogels with a 3D stiffness gradient. J. Tissue Eng. Regener. Med. 2014, 10.1002/term.1908
120. Wu, A.; Loutherback, K.; Lambert, G.; Estévez-Salmerón, L.; Tlsty, T. D.; Austin, R. H.; Sturm, J. C. Cell motility and drug gradients in the emergence of resistance to chemotherapy Proc. Natl. Acad. Sci. U. S. A. 2013, 110 (40) 16103-16108 10.1073/pnas.1314385110
121. Kwapiszewska, K.; Michalczuk, A.; Rybka, M.; Kwapiszewski, R.; Brzózka, Z. A microfluidic-based platform for tumour spheroid culture, monitoring and drug screening Lab Chip 2014, 14 (12) 2096-2104 10.1039/C4LC00291A
122. Davis, M. E. Nanoparticle therapeutics: an emerging treatment modality for cancer Nat. Rev. Drug Discovery 2008, 7 (9) 771-782 10.1038/nrd2614
123. Thurber, G. M.; Schmidt, M. M.; Wittrup, K. D. Factors determining antibody distribution in tumors Trends Pharmacol. Sci. 2008, 29 (2) 57-61 10.1016/j.tips.2007.11.004
124. Albanese, A.; Lam, A. K.; Sykes, E. A.; Rocheleau, J. V.; Chan, W. C. Tumour-on-a-chip provides an optical window into nanoparticle tissue transport Nat. Commun. 2013, 4, 2718 10.1038/ncomms3718
125. Toy, R.; Hayden, E.; Camann, A.; Berman, Z.; Vicente, P.; Tran, E.; Meyers, J.; Pansky, J.; Peiris, P. M.; Wu, H. Multimodal in vivo imaging exposes the voyage of nanoparticles in tumor microcirculation ACS Nano 2013, 7 (4) 3118-3129 10.1021/nn3053439
126. Rajkumar, S. V. Multiple myeloma: 2013 update on diagnosis, risk-stratification, and management Am. J. Hematol. 2013, 88 (3) 225-235 10.1002/ajh.23390
127. Kirshner, J.; Thulien, K. J.; Martin, L. D.; Marun, C. D.; Reiman, T.; Belch, A. R.; Pilarski, L. M. A unique three-dimensional model for evaluating the impact of therapy on multiple myeloma Blood 2008, 112 (7) 2935-2945 10.1182/blood-2008-02-142430
128. Zhang, W.; Lee, W. Y.; Siegel, D. S.; Tolias, P.; Zilberberg, J. Patient-Specific 3D Microfluidic Tissue Model for Multiple Myeloma Tissue Eng., Part C 2014, 20, 663 10.1089/ten.tec.2013.0490
129. Choi, S. Y. C.; Lin, D.; Gout, P. W.; Collins, C. C.; Xu, Y.; Wang, Y. Lessons from patient-derived xenografts for better in vitro modeling of human cancer Adv. Drug Delivery Rev. 2014, 79, 222-237 10.1016/j.addr.2014.09.009
130. Santostefano, K. E.; Hamazaki, T.; Biel, N. M.; Jin, S.; Umezawa, A.; Terada, N. A practical guide to induced pluripotent stem cell research using patient samples Lab. Invest. 2015, 95 (1) 4-13 10.1038/labinvest.2014.104
131. Bhatia, S. N.; Ingber, D. E. Microfluidic organs-on-chips Nat. Biotechnol. 2014, 32, 760 10.1038/nbt.2989
132. Huh, D.; Matthews, B. D.; Mammoto, A.; Montoya-Zavala, M.; Hsin, H. Y.; Ingber, D. E. Reconstituting organ-level lung functions on a chip Science 2010, 328 (5986) 1662-1668 10.1126/science.1188302
133. Carraro, A.; Hsu, W.-M.; Kulig, K. M.; Cheung, W. S.; Miller, M. L.; Weinberg, E. J.; Swart, E. F.; Kaazempur-Mofrad, M.; Borenstein, J. T.; Vacanti, J. P. In vitro analysis of a hepatic device with intrinsic microvascular-based channels Biomed. Microdevices 2008, 10 (6) 795-805 10.1007/s10544-008-9194-3
134. Jang, K.-J.; Suh, K.-Y. A multi-layer microfluidic device for efficient culture and analysis of renal tubular cells Lab Chip 2010, 10 (1) 36-42 10.1039/B907515A
135. Park, J.; Koito, H.; Li, J.; Han, A. Microfluidic compartmentalized co-culture platform for CNS axon myelination research Biomed. Microdevices 2009, 11 (6) 1145-1153 10.1007/s10544-009-9331-7
136. Sung, K. E.; Yang, N.; Pehlke, C.; Keely, P. J.; Eliceiri, K. W.; Friedl, A.; Beebe, D. J. Transition to invasion in breast cancer: a microfluidic in vitro model enables examination of spatial and temporal effects Integrative Biology 2011, 3 (4) 439-450 10.1039/C0IB00063A
137. Huh, D.; Hamilton, G. A.; Ingber, D. E. From 3D cell culture to organs-on-chips Trends Cell Biol. 2011, 21 (12) 745-754 10.1016/j.tcb.2011.09.005
138. Hosoya, H.; Kadowaki, K.; Matsusaki, M.; Cabral, H.; Nishihara, H.; Ijichi, H.; Koike, K.; Kataoka, K.; Miyazono, K.; Akashi, M. Engineering fibrotic tissue in pancreatic cancer: A novel three-dimensional model to investigate nanoparticle delivery Biochem. Biophys. Res. Commun. 2012, 419 (1) 32-37 10.1016/j.bbrc.2012.01.117
139. Frieboes, H. B.; Wu, M.; Lowengrub, J.; Decuzzi, P.; Cristini, V. A computational model for predicting nanoparticle accumulation in tumor vasculature PLoS One 2013, 8 (2) e56876 10.1371/journal.pone.0056876
140. Wu, M.; Frieboes, H. B.; Chaplain, M. A. J.; McDougall, S. R.; Cristini, V.; Lowengrub, J. S. The effect of interstitial pressure on therapeutic agent transport: Coupling with the tumor blood and lymphatic vascular systems J. Theor. Biol. 2014, 355 (0) 194-207 10.1016/j.jtbi.2014.04.012
141. Kahn, J.; Tofilon, P. J.; Camphausen, K. Preclinical models in radiation oncology Radiat. Oncol. 2012, 7, 223 10.1186/1748-717X-7-223
142. Oh, K. S.; Han, H.; Yoon, B. D.; Lee, M.; Kim, H.; Seo, D. W.; Seo, J. H.; Kim, K.; Kwon, I. C.; Yuk, S. H. Effect of HIFU treatment on tumor targeting efficacy of docetaxel-loaded Pluronic nanoparticles Colloids Surf., B 2014, 119 (0) 137-144 10.1016/j.colsurfb.2014.05.007
143. Whitney, J.; DeWitt, M.; Whited, B. M.; Carswell, W.; Simon, A.; Rylander, C. G.; Rylander, M. N. 3D viability imaging of tumor phantoms treated with single-walled carbon nanohorns and photothermal therapy Nanotechnology 2013, 24 (27) 275102 10.1088/0957-4484/24/27/275102
144. Arena, C. B.; Szot, C. S.; Garcia, P. A.; Rylander, M. N.; Davalos, R. V. A three-dimensional in vitro tumor platform for modeling therapeutic irreversible electroporation Biophys. J. 2012, 103 (9) 2033-2042 10.1016/j.bpj.2012.09.017
145. Day, E. S.; Bickford, L. R.; Slater, J. H.; Riggall, N. S.; Drezek, R. A.; West, J. L. Antibody-conjugated gold-gold sulfide nanoparticles as multifunctional agents for imaging and therapy of breast cancer Int. J. Nanomed. 2010, 5, 445 10.2147/IJN.S10881
146. Wang, Z.; Aarya, I.; Gueorguieva, M.; Liu, D.; Luo, H.; Manfredi, L.; Wang, L.; McLean, D.; Coleman, S.; Brown, S. Image-based 3D modeling and validation of radiofrequency interstitial tumor ablation using a tissue-mimicking breast phantom International journal of computer assisted radiology and surgery 2012, 7 (6) 941-948 10.1007/s11548-012-0769-3
147. De Palma, M.; Hanahan, D. The biology of personalized cancer medicine: facing individual complexities underlying hallmark capabilities Mol. Oncol. 2012, 6 (2) 111-127 10.1016/j.molonc.2012.01.011
148. Rangarajan, A.; Weinberg, R. A. Comparative biology of mouse versus human cells: modelling human cancer in mice Nat. Rev. Cancer 2003, 3 (12) 952-959 10.1038/nrc1235
149. Rangarajan, A.; Hong, S. J.; Gifford, A.; Weinberg, R. A. Species-and cell type-specific requirements for cellular transformation Cancer Cell 2004, 6 (2) 171-183 10.1016/j.ccr.2004.07.009
150. Torphy, R. J.; Tignanelli, C. J.; Kamande, J. W.; Moffitt, R. A.; Herrera Loeza, S. G.; Soper, S. A.; Yeh, J. J. Circulating Tumor Cells as a Biomarker of Response to Treatment in Patient-Derived Xenograft Mouse Models of Pancreatic Adenocarcinoma PLoS One 2014, 9 (2) e89474 10.1371/journal.pone.0089474
151. Tentler, J. J.; Tan, A. C.; Weekes, C. D.; Jimeno, A.; Leong, S.; Pitts, T. M.; Arcaroli, J. J.; Messersmith, W. A.; Eckhardt, S. G. Patient-derived tumour xenografts as models for oncology drug development Nat. Rev. Clin. Oncol. 2012, 9 (6) 338-350 10.1038/nrclinonc.2012.61
152. Johnson, H.; Del Rosario, A. M.; Bryson, B. D.; Schroeder, M. A.; Sarkaria, J. N.; White, F. M. Molecular characterization of EGFR and EGFRvIII signaling networks in human glioblastoma tumor xenografts Mol. Cell. Proteomics 2012, 11 (12) 1724-1740 10.1074/mcp.M112.019984
153. Laufer, J.; Johnson, P.; Zhang, E.; Treeby, B.; Cox, B.; Pedley, B.; Beard, P. In vivo preclinical photoacoustic imaging of tumor vasculature development and therapy J. Biomed. Opt. 2012, 17 (5) 0560161-0560168 10.1117/1.JBO.17.5.056016
154. Chung, S.; Sudo, R.; Mack, P. J.; Wan, C.-R.; Vickerman, V.; Kamm, R. D. Cell migration into scaffolds under co-culture conditions in a microfluidic platform Lab Chip 2009, 9 (2) 269-275 10.1039/B807585A
155. Horman, S. R.; To, J.; Orth, A. P.; Slawny, N.; Cuddihy, M. J.; Caracino, D. High-content analysis of three-dimensional tumor spheroids: investigating signaling pathways using small hairpin RNA Nat. Methods 2013, 10, 10
156. Ward, A.; Quinn, K. P.; Bellas, E.; Georgakoudi, I.; Kaplan, D. L. Noninvasive metabolic imaging of engineered 3D human adipose tissue in a perfusion bioreactor PLoS One 2013, 8 (2) e55696 10.1371/journal.pone.0055696
157. Miller, J. S.; Stevens, K. R.; Yang, M. T.; Baker, B. M.; Nguyen, D.-H. T.; Cohen, D. M.; Toro, E.; Chen, A. A.; Galie, P. A.; Yu, X. et al. Rapid casting of patterned vascular networks for perfusable engineered three-dimensional tissues Nat. Mater. 2012, 11 (9) 768-774 10.1038/nmat3357
158. Zheng, Y.; Chen, J.; Craven, M.; Choi, N. W.; Totorica, S.; Diaz-Santana, A.; Kermani, P.; Hempstead, B.; Fischbach-Teschl, C.; López, J. A. In vitro microvessels for the study of angiogenesis and thrombosis Proc. Natl. Acad. Sci. U. S. A. 2012, 109 (24) 9342-9347 10.1073/pnas.1201240109
159. Ehsan, S. M.; Welch-Reardon, K. M.; Waterman, M. L.; Hughes, C. C.; George, S. C. A three-dimensional in vitro model of tumor cell intravasation Integrative Biology 2014, 6 (6) 603-610 10.1039/c3ib40170g
160. Chung, B. G.; Flanagan, L. A.; Rhee, S. W.; Schwartz, P. H.; Lee, A. P.; Monuki, E. S.; Jeon, N. L. Human neural stem cell growth and differentiation in a gradient-generating microfluidic device Lab Chip 2005, 5 (4) 401-406 10.1039/b417651k